- Home
- LUCD vs IRWD Comparison
LUCD vs IRWD Comparison
Compare LUCD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- IRWD
- Stock Information
- Founded
- LUCD 2018
- IRWD 1998
- Country
- LUCD United States
- IRWD United States
- Employees
- LUCD 70
- IRWD N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- LUCD Health Care
- IRWD Health Care
- Exchange
- LUCD Nasdaq
- IRWD Nasdaq
- Market Cap
- LUCD 108.0M
- IRWD 111.2M
- IPO Year
- LUCD 2021
- IRWD 2010
- Fundamental
- Price
- LUCD $1.07
- IRWD $1.32
- Analyst Decision
- LUCD Strong Buy
- IRWD Buy
- Analyst Count
- LUCD 5
- IRWD 5
- Target Price
- LUCD $3.65
- IRWD $4.94
- AVG Volume (30 Days)
- LUCD 1.6M
- IRWD 1.2M
- Earning Date
- LUCD 11-12-2025
- IRWD 11-06-2025
- Dividend Yield
- LUCD N/A
- IRWD N/A
- EPS Growth
- LUCD N/A
- IRWD N/A
- EPS
- LUCD N/A
- IRWD N/A
- Revenue
- LUCD $4,360,000.00
- IRWD $308,519,000.00
- Revenue This Year
- LUCD $22.80
- IRWD N/A
- Revenue Next Year
- LUCD $221.19
- IRWD N/A
- P/E Ratio
- LUCD N/A
- IRWD N/A
- Revenue Growth
- LUCD 14.74
- IRWD N/A
- 52 Week Low
- LUCD $0.73
- IRWD $0.53
- 52 Week High
- LUCD $1.80
- IRWD $5.13
- Technical
- Relative Strength Index (RSI)
- LUCD 50.26
- IRWD 55.73
- Support Level
- LUCD N/A
- IRWD $1.05
- Resistance Level
- LUCD $1.09
- IRWD $1.32
- Average True Range (ATR)
- LUCD 0.09
- IRWD 0.08
- MACD
- LUCD -0.06
- IRWD -0.07
- Stochastic Oscillator
- LUCD 69.53
- IRWD 95.99
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.